Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://luclwxv176535.prublogger.com/37929396/retaglutide-a-promising-glp-1-receptor-agonist